seed
Stage
1
Investors
About
Sincrolab is a digital therapeutic app offering a personalized 6-month treatment for children with attention difficulties (TDAH), combining daily gamified training, professional monitoring and online evaluations. The platform is CE-marked and lists ISO certifications, aiming to improve attention, organization and family well-being from home.
Explore Sincrolab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.